The development of melanoblasts in normally pigmented and dominant spatting ( W) embryos was followed by in situ hybridisation to TRP-UDT mRNA, which labels migratory melanoblasts from 10 days post coitum. Numerous melanoblasts migrate to the inner ear around 11 days. In contrast, few migratory melanoblasts are associated with the eye or skin at this stage and melanoblast distribution within the trunk and tail is patchy. The distribution of melanoblasts in 10.5-l l-day-old WV/W', WShlWSh and w'lw" mutants was similar to that in controls but melanoblast density was lower and by 12 days was severely reduced. These results suggest that mutations of the c-kit receptor tyrosine kinase encoded at the W locus do not alter early migration or differentiation of melanoblasts but severely affect melanoblast survival.
Introduction
Neural crest derived melanocytes occur in a variety of sites, including the skin, hair follicles, the inner ear and the choroid and Harderian gland of the eye. Transplantation experiments revealed that migratory melanoblasts in the mouse trunk first flank dorso-lateral folds of the embryo at 8 days post coitum (dpc) and then migrate laterally in the body wall towards the ventrum, entering the ectoderm of the skin on day 12 (Rawles, 1947) . All coat melanoblasts appear to be derived from a limited number of clonal initiator cells (Mintz, 1967) . More specific details of the pathways and timing of melanoblast migration are largely unknown as melanoblasts cannot generally be distinguished from other mesenchymal cells until they have differentiated into pigmented melanocytes. However, a recent study * Corresponding author, Tel.: 0272 303738; Fax: 0272 257374. ' School of Biological Sciences, University of Bristol, Bristol BS8 IUG, UK. has shown that the tyrosinase and tyrosinase-related proteins 1 and 2 (TRP-1 and TRP-2) genes can be used as specific markers to detect melanoblasts by in situ hybridisation to mRNA . TRP-2 is the melanogenic enzyme DOPAchrome tautomerase (DT), which converts DOPAchrome to 5, 6-dihydroxyindole carboxylic acid (Tsukamoto et al., 1992) . TRP-2 is therefore involved in the later stages of the melanin synthesis pathway but, nevertheless, is expressed early in development and can be used to detect melanoblasts shortly after they leave the neural crest around 10 days of gestation, 6 days before visible melanin can be detected in melanocytes. Tyrosinase and TRP-1 probes also detect melanoblasts but both are expressed later in development at 14.5 dpc . TRP-2 is therefore the first mammalian neural crest marker that clearly identifies the melanoblast cell lineage from a very early stage .
The availability of this melanoblast-specific marker provides a means of studying the normal process of melanoblast migration, proliferation, survival and differentiation as well as studying melanoblast develop- Steel, Rump-white, Microphthalmia-white and piebaldlethal) have white coats as the skin is devoid of melanocytes (Silvers, 1979) . The genetic basis of some of these spotting mutations is known but it is unclear how they affect melanoblast development. Dominant spotting (W) encodes the proto-oncogene c-kit (Chabot et al., 1988; Geissler et al., 1988) which is a growth factor receptor and a member of the receptor tyrosine kinase (RTK) family that have a single membrane-spanning domain. Interaction of the extracellular domain with the ligand, Steel factor, encoded at the Sl locus (Copeland et al., 1990; Huang et al., 1990; Zsebo et al., 1990) stimulates receptor dimerization, transient activation of the intracellular tyrosine kinase domain and phosphorylation (reviews by Ullrich and Schlessinger, 1990; Kock et al., 1991) . Mutations at the Wlocus affect embryonic hemopoietic tissues, primordial germ cells and melanoblasts derived from the neural crest, These three cell lineages do not share a common precursor but are linked by the fact that they all undergo extensive proliferation and migration during development. The @' and W" mutations are both point mutations in the c-kit kinase domain , whereas the molecular basis of the Wsh allele is not yet fully described but probably arises from a deletion or rearrangement in the region of the c-kit gene which affects its expression (Duttlinger et al., 1993) . It has been shown that W"/W" mutants produce normal levels of c-kit protein but with reduced kinase activity (Reith et al., 1990) . Variable expression of the mutation arises as the c-kit receptor is only partially impaired . Duttlinger et al. (1993) proposed that c-kit ectopic over-expression in the dermatome of 10.5 and 11.5 dpc Wsh/Wsh embryos may result in binding with all available Steel factor. This would reduce the amount of ligand available for c-kit-expressing melanoblasts migrating over the dermatome and ultimately affect the survival and/or proliferation of melanoblasts at this site (Duttlinger et al., 1993) . Expression of c-kit mRNA within the three major cell types affected by the mutations correlates well with the W phenotypes (Nocka et al., 1989; OrrUrtreger et al., 1990; Manova and Bachvarova, 1991) . Similarly, the Steel factor is expressed during embryogenesis in the cells associated with both the migratory pathway and target sites of melanoblasts (e.g. Matsui et al., 1990) .
Several of the white spotting mutants have had their hearing assessed and are hearing-impaired due to a lack of melanocytes within the stria vascularis of the inner ear (e.g. Deol, 1970a,b; Grainger et al., in preparation; Schrott and Spoendlin, 1987; Steel et al., 1987; Cable et al., 1992) . The stria vascularis, which lines the lateral wall of the cochlea, is responsible for the production and maintenance of the endocochlear potential (EP), which is about 100 mV in normally hearing mice (e.g. Steel and Bock, 1980 ). An absence of melanocytes prevents the stria developing structurally and functionally, no EP is produced and this leads to secondary degeneration of the sensory hair cells within the organ of Corti (Steel and Barkway, 1989; Steel et al., 1987) .
The Steel-dickie (Sl"> mutation is a small internal deletion of the Steel gene which results in the encoded protein lacking its transmembrane and cytoplasmic domains (Brannan et al., 1991; Flanagan et al., 1991) . Homozygous Sld/Sld mice have no external pigmentation and all are hearing-impaired due to a lack of strial melanocytes (Grainger et al., in preparation) . Using TRP-2 as a melanoblast probe, Steel et al. (1992) found that the membrane-bound growth factor which is missing in SldlSld mutants is necessary for the survival of melanoblasts but not for their initial migration and early differentiation.
Previous studies comparing the inner ear pigmentation with cochlear potentials in various W mutants (II"', Wsh and W4') revealed an unequivocal correlation between presence of strial melanocytes and presence of an EP (Cable et al., 1992 (Cable et al., , 1994 . Asymmetry was common and 11% of VI W', 25% of Wshl Wh and 69% of ~'I~' ears had a pigmented stria and an EP, while the remainder had no strial melanocytes and no EP. Having described the end effects of the mutations, we used TRP-2 in the current study to look at the detailed distribution of melanoblasts in controls and to determine which stage of melanoblast development was defective in the W allele mutants.
Results

Developmental pattern of TRP-2 expression in normally pigmented (CBA/Ca and +I+) mice
The pattern of TRP-2 distribution in normally pigmented mice is similar to that previously described by Steel et al. (1992) . This former study concentrated on observations of the head region and as several different riboprobes were used as melanoblast markers on consecutive sections, quantitative estimates of TRP-2 expression were not possible. In the current study, we used TRP-2 as the sole marker for melanoblasts and looked at expression within serial sections of whole embryos. Within the mesenchyme and ectoderm and around the inner ear and much of the eye, TRP-2 appears to be localised to single cells that we propose are melanoblasts (see Steel et al., 1992) . In contrast, TRP-2 expression in the brain, pigmented retinal epithelium (PRE) and endolymphatic duct occurs within groups of adjacent cells. TRP-2 expression in the brain of control mice has been described in full by Steel et al., (1992) .
2.1.1. TRP-2 expression in the mesenchyme and skin of controi mice. The distribution of ectodermal and mesenchymal melanoblasts (excluding all labelled cells associ-10.5 dpc 13 dpc 11.5 dpc 14 dpc Fig. I . The distribution of mesenchymal and ectodermal melanoblasts in control embryos. The black dots represent the distribution of TRP-2 labelled cells not the actual number recorded from serial sections. Isolated melanoblasts are first detected at 10 days of gestation in the mesenchyme overlying the otic vesicle. Around 11 dpc, melanoblasts appear in the mesenchyme around the brain. By 11.5 dpc, around 1 600 melanoblasts are detected. This number increases to around 4 500 at 12 dpc and 17 500 at I3 dpc as melanoblasts extend along the trunk on either side of the neural tube. As melanoblasts become more numerous in the trunk, they also migrate laterally away from the neural tube. High concentrations of melanoblasts are found in the pinna in most embryos from 12 dpc. No melanoblasts are seen along the dorsal midline. ated with the choroid, Harderian gland and inner ear) is illustrated in Figs. 1 and 2: numbers of these melanoblasts were only counted in those embryos where tissue preservation and hybridisation was of good quality throughout the specimen (Table 1) . Initially, a few isolated cells are detected in lo-day-old embryos underlying the surface ectoderm in the region of the otic vesicle. At 10.5 dpc, a few melanoblasts are detected in the lateral mesenchyme adjacent to the fore-and hindbrain (but not the midbrain). This group of melanoblasts becomes more prominent in 11 and 11.5-day-old embryos and many are local&d to the anterior cardinal vein (acv), particularly near the otic vesicle. Only small numbers of melanoblasts are detected in the trunk mesenchyme and none are apparent in the overlying ectoderm at 10-l 1 dpc. TRP-2 expressing cells in the tail are few or absent.
In 12 and 13-day-old embryos, there is still no TRP-2 mRNA in the mesenchyme near the mesencephalon of the developing midbrain but a stream of melanoblasts extends between the myelencephalon and telencephalon. At 12 dpc, melanoblasts are scattered along the dorsal half of the lateral surfaces but no labelled cells lie along the dorsal midline. Extensive colonization of labelled cells is usually found in the developing pinna and a second cluster is often apparent just dorsal to the eye. By 13 days, melanoblasts extend along the entire lateral surfaces in many regions of the head with particularly high concentrations between the pinna ( Fig. 2A) and eyes. Caudal to the pharynx and oral cavity, the majority of melanoblasts are located dorso-laterally just ventral to the neural tube. Melanoblasts are associated with the acv along its entire length extending from the head Fig. 2 . In situ hybridisation of mesenchymal and skin melanoblasts in controls and mutants. e, epidermis; d, dermis; LB, limb bud; NT, neural tube. Scale bars = 100 pm. (A) CBAKa, 13.5 dpc, melanoblasts aggregated within the surface ectoderm and underlying mesenchyme of the pinna. (B) CBA/Ca, 12.5 dpc, melanoblasts at the base of the tail lying adjacent to the hindlimb buds. (C) W4'lW 4' 13 dpc, clusters of melanoblasts at , the base of the tail. (D) CBAKa, newborn, TRP-2 expression within the dermis and hair follicles (arrows). (E) W*/Wh, newborn, in contrast to the control there is no TRP-2 expression within the skin.
to the heart and are scattered along the posterior carat the base of the hindlimbs (Fig. 2B ). At 13 dpc, the madinal vein (pcv). The distribution and number of cells in jority of melanoblasts lie within the mesenchyme. more caudal sections becomes increasingly patchy By 14 days, the abundance of TRP-2 expressing cells although a large aggregation of melanoblasts usually lies has greatly increased. A few melanoblasts now lie in the Table 1 Approximate number of melanoblasts within the developing skin and underlying mesenchyme of CBA/Ca embryos Age (dpc) mesenchyme surrounding the mesencephalon and putative skin melanoblasts in the ectoderm and underlying mesenchyme have become more widespread. However, there are still areas of developing skin, especially in the trunk, devoid of melanoblasts. No labelled cells were observed along the dorsal midline in the head or trunk. At birth, large numbers of melanocytes are uniformly distributed within the dermis and hair follicles of the skin (Fig. ZD) . 2.1.2. TRP-2 expression associated with the eyes of control mice. TRP-2 is first detected in 9.5-day-old embryos within the presumptive pigmented retinal epithelium (PRE) of the eye. Melanocytes which form the PRE develop from locally derived neuroectoderm rather than neural crest. Labelling is localised along the ventral medial edge of the spherical optic vesicle (Fig. 3A) . By 10 days of gestation, the optic vesicle has begun to invaginate and intense TRP-2 staining is evident along the entire PRE. Similar TRP-2 expression in the PRE is observed in all older embryos and neonates.
Migratory melanoblasts associated with the eye are first detected at 11 dpc, just caudal to the eye. At 11.5 dpc, a few isolated melanoblasts are also localised dorsal and ventral to the eyes, just below or within the ectoderm; some pigment is detected at this stage in the PRE but not yet in the migratory melanoblasts. Melanoblasts located medial to the eye, probably destined for the choroid and/or Harderian gland, are not detected until 12 dpc when ventrally positioned cells extend out in a medial direction from the eye. The Harderian gland is an accessory gland of the eye which encloses much of the optic cup. It is heavily pigmented in adults but the function of its melanocytes is unknown. In 12-day-old embryos, TRP-2 expressing cells are common in the mesenchyme around the eye except in the region of the developing choroid medial to the PRE. At 13 dpc, presumptive choroidal melanoblasts lie scattered just below the PRE around its entire rim (Fig. 3E) but are more numerous in medial than peripheral sections. Many melanoblasts lie within the developing skin that forms the eyelids. Occasionally, a group of melanoblasts are detected near the optic nerve. At 14 dpc, many melanoblasts are found in the surface ectoderm and underlying mesenchyme surrounding the eye. There are still very few putative choroidal melanoblasts, but many TRP-2 labelled cells appear to occupy the Harderian gland (Fig. 3G ). At birth, there is an intense uniform layer of TRP-2 expression over the entire PRE which is locally thickened in isolated patches on the convex surface. This thickening probably represents choroidal melanocytes. TRP-2 labelling is also apparent in the ciliary body and numerous dendritic melanocytes lie in the Harderian gland.
2.1.3. TRP-2 expression associated with the inner ears of control mice. At 10 dpc, just one or two melanoblasts are evident, ventral to the inner ear. A day later, large numbers of melanoblasts are associated with the otic vesicle (around 270; Fig. 5 ) particularly along the dorsal edge (Fig. 4A ). In the vestibular and cochlear portions of the developing ear, melanoblasts are present in the mesenchyme on all sides of the otocyst and around the acv.
Around 12 days of gestation, the inner ear undergoes extensive morphogenetic changes; the endolymphatic duct is now prominent, the ducts of the vestibular region begin to differentiate and the ventral region of the otic vesicle elongates to form the coils of the cochlea. There is no obvious increase in the number of melanoblasts associated with the inner ear between 11 and 12 dpc (Fig. 5) but the labelled cells now appear to be targeting specific regions of the ear. In the anterior-most sections of the vestibular region, just a few labelled cells lie around the semi-circular canals. However, numerous melanoblasts surround the sacculus and these clusters of labelled cells increase in number towards the base of the developing cochlea (Fig. 4D) . Caudal to the inner ear, several TRP-2 expressing cells are enclosed within the mesenchymal auditory capsule and within the tissue surrounding the adjacent acv. It is unknown whether the melanoblasts associated with the acv eventually migrate to the inner ear, to another target site or whether they remain associated with this vein throughout development. Although acv melanoblasts overlying, and perhaps caudal to, the inner ear may migrate to the vestibular region or cochlea (this being a fairly direct route from the neural crest), it seems unlikely that melanoblasts associated with the acv and pcv in the trunk should target the ear following an extended Lshaped migration pathway from the crest.
In the 13-day-old embryos, there is still comparatively little TRP-2 expression around the semi-circular canals but melanoblasts are abundant where the endolymphatic duct joins the vestibular region. The greatest concentration of melanoblasts occurs around the sacculus and base of the cochlear duct. Numerous melanoblasts lie in close proximity to the basal cochlear turn (Fig.  4F) , concentrated along the ventral edge of the neuroepithelium (which later differentiates into the stria vascularis) but are occasionally found in a dorsal position. Only a small number of melanoblasts are associated with the apical cochlear turn at this stage of development, reflecting the base to apex differentiation of the cochlea and stria vascularis (e.g. Kikuchi and Hilding, 1966) . A few melanoblasts extend caudally beyond the cochlear apex within the auditory capsule and are often located close to the ventral edge of the acv.
At 14 dpc, melanoblasts are abundant within the vestibular region. The density of labelled cells around the cochlear turns is variable but most melanoblasts are restricted to the ventral edge of the duct. In the newborn mouse, melanocytes lie within the stria vascularis of each cochlear turn and within the utricle, crus commune and ampullae of the vestibular region (data not shown). This distribution corresponds well with the known adult distribution of melanocytes (e.g. Cable et al., 1994) .
TRP-2 was also expressed in the epithelium of the Embryo age (dpc) Fig. 5 . Quantitative estimate of inner ear melanoblasts. Each point represents the number of melanoblasts counted from serial sections that were associated with a particular inner ear. In the CBA/CA controls, the number of melanoblasts increased from < IO cells at IO dpc to around I 700 at 14.5 dpc. Greatest variability was detected in the period of active inner ear morphogenesis around I I .5-I2 dpc. Only a small sample of IV"/+ controls were examined but in these the number of melanoblasts was greatly reduced compared to the CBA/Ca mice. At early developmental stages, similar numbers of melanoblasts were detected in the p'i@', W**IWsh and W/W" mutants and controls, however, between II.5 and I2 days there appeared to be a reduction in the number of melanoblasts detected in the mutants. Thereafter, very few melanoblasts were identified in the mutant inner ears.
endolymphatic duct in about 20% of the embryos examined aged 10.5-14 dpc. This distribution suggests that TRP-2 activity in this tissue is derived from epithelial cells rather than from migratory melanoblasts.
Expression of TRP-2 in V/+ mutant mice
Observations on four heterozygous W mutants revealed a similar pattern of TRP-2 expression to that observed in control embryos (see above). However, the abundance of migratory melanoblasts in W/+ embryos was greatly reduced compared with controls at all developmental stages. Even in the lCday-old embryo examined, relatively few melanoblasts were detected in the mesenchyme and developing skin or associated with the eye or inner ear (Fig. 5 ).
Expression of TRP-2 in W homozygous mutant mice
Fewer neural crest-derived melanoblasts are detected in most tissues of W4'lW4' , WShl WSh and WI W mutants compared with controls. In general, larger numbers of these migratory melanoblasts were detected in W4'lpJ and WI W compared to WShl Wh embryos. TRP-2 expression in the forebrain (data not shown), endolymphatic duct and PRE (Fig. 3) of the embryos is just as intense and has a similar distribution to that described above in normally pigmented control mice.
Within the inner ear, relatively large numbers of melanoblasts are visible in mutants at 11 and 11.5 days of gestation ( Fig. 4A and B) and the general pattern of melanoblast distribution is similar to that in controls. However, the density of melanoblasts, even at this early developmental stage, is lower than that in controls, especially in Whl WSh and W/W embryos. Between 11.5 and 12 dpc in WShl WSh and W'l W' (and between 11 and 12 dpc in W/W) mutants, the difference in melanoblast density compared with controls becomes even more apparent. Thereafter, only a few labelled cells are associated with the inner ear of mutant embryos (Fig. 4) . This is particularly noticeable in the W4'lW4' mice which have a relatively high number of inner ear melanoblasts in young 11 and 11.5 dpc embryos (mean labelled cell number of 72) compared with older 12-to lCday-old embryos (mean 8).
The pattern of melanoblast development within the inner ears -an apparently normal migration of melanoblasts from the neural crest followed by a reduc-tion in number of cells at the target site -was also observed in the choroid and Harderian gland of mutants (Fig. 3) .
It was more difficult to analyse the development of pigmentation in the skin compared to that in the sensory organs as the target site is obviously more diffuse and there is considerable variation in numbers of melanoblasts in the control group. However, the abundance of mesenchymal and ectodermal melanoblasts in young mutant embryos was reduced compared to controls and very few skin melanoblasts were detected in older embryos and neonates (Fig. 2E) . High concentrations of cells were occasionally observed, especially in the tail of several @'lpl embryos (Fig. 2C) , and the newborn Wshl Wsh mouse had a patch of pigmented skin on the snout. This correlates with the observations of adult mice in which a proportion of mutants have some external pigment. Not surprisingly, W4'/p' embryos were the only mutants to have a high concentration of melanoblasts within the developing pinna as the pinnae of all adults (in contrast to Wsh/Wsh and w/W" mutants) are always pigmented.
Discusfion
In situ hybridisation using TRP-2 as a probe reveals that melanoblasts in normally pigmented mouse embryos appear to migrate ventrally as diffuse streams, rather than in compact masses, and there is no obvious mixing of crest cells across the dorsal midline. The probe detects melanoblasts after they leave the neural crest, around 10 dpc, so it is difficult to determine which region of the crest they originate from. The majority of labelled cells are detected in the mesenchyme surrounding the lateral edges of the neural tube initially between the fore-and hindbrain (but not the midbrain) and gradually extending to more rostra1 and caudal sites. There is no clear division of melanoblasts into the two migration pathways identified for other neural crest cells: (i) ventrally through the mesenchyme and (ii) subectodermally. Most cranial melanoblasts migrate within the mesenchyme and in later developmental stages (around 13 dpc) become more abundant subectodermally. Trunk and tail melanoblasts are largely found subectodermally with just a few labelled cells found in more internal sites, for example, associated with the posterior cardinal vein or respiratory tract.
Melanoblasts were first detected in the ectoderm at 11.5 dpc. Proliferation, or further migration, of melanoblasts in the mesodermal layer around 12 and 13 dpc leads to the entry of additional cells into the ectoderm. Mayer (1973) has shown that melanoblasts invade the epidermis by penetrating the basement membrane from the dermis of the trunk skin between prenatal day 11 and 12. By 13 or 14 dpc, melanocytes have finished colonization of the epidermis (Mayer, 1973) and around day 15, melanocytes migrate from the epidermis into the developing hair follicles (Hirobe, 1984) . Epidermal melanocytes in hairy trunk skin begin the production of premelanosomes on day 14 and become dopa-positive on prenatal day 16 and increase in number until postnatal day 4. Thereafter, dopa-positive melanocytes gradually decrease in number and by day 30, they can no longer be detected but they do persist in the epidermis in a non-pigmented state (Quevedo et al., 1966; Silvers, 1979; Hirobe, 1984) . In contrast, melanocytes in the non-hairy skin of the ear, nose and tail remain in the epidermis of adult mice (Silvers, 1979) . In our lCdpcmouse embryos, large aggregates of labelled cells were identified in the ectoderm of the head, particularly in the pinna and in the region of the eye. However, relatively few melanoblasts were detected in the trunk ectoderm. The small numbers of melanoblasts visible in the trunk skin supports previous work on chimaeric and transgenic mice which suggests that large areas of the coat are pigmented by descendants from single precursors (Mintz, 1967; Huszar et al., 1991; Mintz and Bradl, 1991) .
Many melanoblasts which migrate deep within the mesenchyme lie close to the posterior and especially the anterior cardinal vein. This association supports previous observations that structural heterogeneities, such as blood vessels and the neural tube, may act to confine the direction of migrating crest cells (Tan and MorrissKay, 1986) . Apart from achieving a blockade effect, these structures may also serve as a contact guide for migrating cells (Weiss, 1958; Noden, 1975) . However, it is unclear whether the melanoblasts associated with the cardinal veins are destined for the skin or are targeting some internal site. In addition to the target sites already mentioned (skin, ear and eye), melanocytes are also associated with the meninges of the brain, the parathyroid, the thymus, the ovary and the spleen (Markert and Silvers, 1956; Silvers, unpublished, cited in Billingham and Silvers, 1960) .
It is possible that not all neural crest cells are derived from the neural tube. TRP-2 does not detect melanoblasts immediately when they leave the neural crest so it is necessary to consider the possibility of other sources for migratory melanoblasts. Other regions where a neuroepithelium borders an ectodermal epithelium such as otic, optic and nasal placodes may give rise to neural crest-like migratory cells (O'Rahilly and Milller, 1987; Mom-y and Jacobson, 1989) .
Using in situ hybridisation, it is not possible to identify the exact timing and the different stages of melanoblast migration and proliferation but the melanoblasts associated with a particular tissue, or even different regions of the skin, appear to show distinct developmental patterns. A large population of melanoblasts migrate to the inner ear early in development which presumably then undergoes a second stage of proliferation. In contrast, relatively few melanoblasts target the skin or the eye but these cells presumably undergo much more extensive proliferation in late prenatal or even postnatal stages of development.
The current study suggests that a fully-active c-kit protein is not required for the early migration and targeting of melanoblasts because the distribution of melanoblasts is similar in young mutant embryos compared with controls. The differentiation of melanoblasts also occurs in the absence of normal c-kit, because we observe expression of TRP-2 in young mutant melanoblasts and, in addition, some fully-differentiated melanocytes are seen in the adult homozygous mutants (Cable et al., 1994) . The major effect on melanocytes of the functional impairment of the c-kit protein, in the three mutants studied, appears to be to reduce the numbers of melanoblasts surviving. In WY and W4' homozygotes, there is a clear reduction in melanoblast numbers between 11 and 12-14 dpc and, even in the most severely affected mutant, Wsh/ Wsh, there appears to be a reduction in older embryos compared with younger ones. None of the mutants appeared to have a normal complement of melanoblasts even at 10.5-l 1 dpc, which could be due to some melanoblasts dying before they start to express TRP-2 (i.e. c-kit is required as a survival factor before this stage of development), or it might reflect an influence of c-kit on the numbers of neural crest cells committed to a melanocyte fate. A third possibility is that melanoblast proliferation is affected by the mutations.
As a specific target for melanoblasts, the inner ear provides a useful organ for comparison in controls and mutants. Surprisingly, of the 36 mutant inner ears examined from embryos aged 12 days and older, all had a low number of melanoblasts compared to controls. We have previously shown that around 11% of IV'/ W", 25% of Wshl Wsh and 69% of @'l W41 adult cochleas have some pigmentation of their strias (Cable et al., 1992; . This suggests that there is a later stage of melanoblast proliferation within the inner ear, unaffected by c-kit, and that if some melanoblasts survive in a mutant inner ear, they may proliferate at this later time to give partial population of the stria. In the II"'/+ embryos examined, the number of melanoblasts, particularly within the inner ear, was greatly reduced compared with controls. However, adult IV"/+ mice have normal hearing and, although no quantitative estimates of strial melanocytes in adults has been attempted, they appear to have normal levels of inner ear pigmentation (Cable et al., 1992) . This suggests that in +/+ mice more melanoblasts reach the inner ear than the number actually needed to proliferate and provide a normal complement of adult melanocytes. Alternatively, the inner ear melanoblasts of WV/+ embryos may undergo more extensive proliferation compared to the controls to compensate for the lower number of pigment cells which initially target the ear.
The coat of WV/+ adults is dilute and contains fewer melanocytes than normally pigmented mice. Furthermore, white head and belly spots are characteristic of this genotype. Mintz (1969) concluded that various white spotting patterns could be explained by (i) preprogrammed melanoblast death controlled by a cell autonomous gene or (ii) advanced developmental closure of certain skin sites which consequently are not seeded with melanoblasts, and/or (iii) distal location of certain skin sites which, owing to their remoteness, might not receive migratory melanoblasts in the event of any perturbation in development. Thus, the white feet, tail, belly spot and head spot of W heterozygotes may occur as they are all distally situated in the melanoblast migratory pathway or else in locations in which the neural fold is late closing, ie. the umbilical region and near the anterior neuropore (Mintz, 1971) . Pigmentation in W homozygotes is commonly observed on the pinna (Silvers, 1979) and Yoshida et al. (1993) found that after injecting normally pigmented pregnant mice with anti-ckit antibody (ACK2), pigmentation was always present on the pinnae (and often at the base of the tail) in the offspring. The authors suggested that c-kit may be an important factor controlling long distance cell migrations; melanoblasts which pigment the pinnae only migrate a short distance from the neural crest and therefore are not affected by ACK2 injections (Yoshida et al., 1993) . However, if this is the case, it is surprising that inner ear melanoblasts are so severely affected in W mutants because presumably the distance of their migration pathway is very similar to that of the pinna melanoblasts. Our observations suggest that melanoblast distribution in the embryo is irregular, with some regions having a high density of these cells, which may make it difficult for either a mutation or an antibody to eliminate all the melanoblasts in these denselypopulated regions.
Our understanding of the action of the W locus is gradually accumulating. We have shown in this study that the c-kit gene primarily affects the survival of migratory melanoblasts. It is also known that c-kit regulates melanoblast development in the epidermis from 10.5 to 14.5 dpc and that c-kit is required for melanocyte activation which occurs at the start of each hair cycle throughout life (Nishikawa et al., 1991) . c-kit does not appear essential for early migrations or, possibly, short distance migrations during embryogenesis (Yoshida et al., 1993; current study) . In the cochlea, c-kit appears to be important only for development and not for mature melanocyte function (Cable et al., 1992) . There may be several other dependant processes during melanocyte development. We have no evidence yet as to whether c-kit or Steel factor affect the proliferation of melanoblasts in vivo. Synchronous expression of c-kit and Steel factor in a variety of tissues, such as the brain, that are not overtly affected by Wand Sl mutations suggests that the receptor-ligand system has additional roles in embryogenesis (Manova and Bachvarova, 1991; Matsui et al., 1990 ) and post-natal development (Manova et al., 1992) .
We have found the TRP-2/DT probe extremely useful in identifying melanoblasts at early stages of development, as discussed previously . It has some advantages over the use of c-kit as a specific melanoblast marker because, unlike c-kit, it does not appear to be expressed in mast cells. Thus, we are contident that the individual labelled cells we observe in the mesenchyme are melanoblasts and that we can detect them using TRP-2/DT some six days before the production of visible pigment allows them to be distinguished. Our observations of relatively few migratory melanoblasts close to the developing skin up to 14 dpc in normal embryos correspond well with observations using an antibody to the TRP-2/DT protein (Pavan and Tilghman, 1994) suggesting also that the mRNA is translated shortly after it is transcribed. Pavan and Tilghman's report of a lack of identifiable melanoblasts at any developmental stage in piebald lethal embryos suggests that this mutation acts at an earlier stage in the developmental pathway of melanocytes than we have found to be the case in W and Sl locus mutants. All these studies emphasise the usefulness of an early marker for melanoblasts.
Experimental procedures
Three mutants were examined in this study: 14 #'I~' and 15 WshlWsh whole embryos aged 9.5-14 dpc and a newborn mouse head from each group, and 8 IV/ IV heads from embryos aged 11-14 dpc. All mutations were bred and maintained on a mixed genetic background (at least 50% CBA). Seventeen embryos and a neonate from the CBA/Ca inbred strain were used as the main control group. W4'l W4' and Wshl Wsh mutants were derived from matings between homozygotes. IV/B" mice are sterile (Silvers, 1979 ) so embryos were obtained from matings between heterozygotes. DNA genotyping was therefore necessary to distinguish homozygotes from heterozygotes and +/+ littermates. DNA was prepared from the body of each embryo by proteinase K digestion followed by phenol extraction and ethanol precipitation. The W' mutation is a threonine to methionine substitution at residue 660 of the Kit protein, due to a C to T transition at base 2007 of the Kit gene ). The transition creates a novel NsiI restriction site which is diagnostic for the mutation. We designed oligonucleotide primers with which to amplify by PCR a DNA fragment that included the mutation. The base change is close to the 3 ' end of exon 13 (following base 2015) and, as the sequence of the adjacent intron 13 from the mouse gene is not known, it was not possible to design a sufficiently long primer for this end of the fragment based on known sequence. We therefore used a composite sequence, incorporating the complement of bases 2015 to 2008 at the 3 ' end and the complement of the published human sequence of intron 13 at the 5 ' end (5 'ACACGGCTTTACCTCCCACC-3') (Giebel et al., 1992) . The resulting 20 mer was used in conjunction with a 20 mer within exon 13 (5 ' AAAGAGAGGCCCTAATGTCG-3 '). PCR reaction conditions were as previously described and the PCR programme was: 2 min at 94"C, 5 cycles at 92°C 1 min, 45°C 1 min and 72°C 1 min, followed by 30 cycles at 92°C 1 min, 55°C 1 min and 72°C 1 min. The reaction products were digested with NsiI and electrophoresed through a 3:l Nusieve:agarose gel. The 105-bp fragment from wild-type DNA is not cut by NsiI, homozygous W" DNA is completely converted to an 84-bp fragment through removal of a 21-bp fragment, consisting of the 3 ' primer plus the variant base, and heterozygous DNA has both 105 and 84-bp fragments. Observations on the expression of TRP-2 were made on the heads of 2 +I+ and 4 WI-+ embryos from these segregating litters in addition to the controls and homozygous mutants mentioned above.
After matings had been set up for 4-8 h, the presence of a vaginal plug was used to indicate that mating had occurred and the date of plug detection was designated Day 0. As the development of littermates varied considerably, particularly around 9-11 dpc, sections of embryos were examined after processing to assess their developmental stage using characteristics such as eye and limb development (Kaufman, 1992; Theiler, 1989) . The age of the embryos below refers to their developmental rather than gestational age. Pregnant mice were killed by cervical dislocation. The embryos were transferred to cold phosphate-buffered saline (PBS) and the decidual and extraembryonic tissues were carefully removed. Newborn mice were decapitated and the heads were cut :In half along the midline. Embryos and half heads were fixed in 4% paraformaldehyde in PBS (pH 7.2)'at 4°C for approximately 12-24 h, washed, dehydrated and embedded in paraffin wax. Transverse serial sections of 8 pm thickness were cut and mounted on TESPA (3-aminopropyltriethoxysilane) coated slides in rows and the last section in a row was set slightly apart and was used as a control, hybridising with the sense strand of TRP-2. In situ hybridisation procedures using TRP-2 probes were carried out as previously described by Steel et al. (1992) .
Sections were examined under light and dark field illumination. A quantitative assessment of melanoblasts involved counting individual cells from serial sections of whole embryos. Putative skin and mesenchymal melanoblasts included all labelled cells other than those associated with the eye or ear. The skin does not begin to differentiate until 14 dpc and, therefore, it was only possible to determine the distribution of melanocytes in the epidermis, dermis and hair follicles of newborn mice. Melanoblasts associated with the inner ear were counted separately and included all positively labelled cells identified within 100 pm of the developing otocyst. In some young embryos where the overlying skin was less than 100 pm from the inner ear, putative skin melanoblasts (usually only one or two cells per specimen) were not included in the inner ear counts. At later developmental stages, when the auditory capsule (bulla) was clearly distinguished from surrounding tissue by its dense mesenchymal cells, measurements were still taken from the outer edge of the inner ear neuroepithelium but labelled cells within the bulla were also included. By determining the ratio of control to probe labelled sections per embryo or per inner ear, the number of labelled cells in control sections was estimated and added to the total. However, no statistical correction factors were introduced to allow for melanoblasts that may have been counted twice in adjacent sections.
